EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity

Simon Nannini, Céline Sieffert, Andrew McGown, Xin-Yue Gao, Amanda Jarvis, Georges E Kostakis, Antal Galvacsi, Csilla Kallay, Ruxandra Moraru, Matthias G Baud, Sebastian Mandel, Dimitros-Ilias Balourdas und 9 weitere

Journal of Enzyme Inhibition and Medicinal Chemistry · 31.12.2026 · 41 (1)

DOI: 10.1080/14756366.2026.2638836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, online erschienen am 21.05.2026. Verfasst von Simon Nannini und 20 weiteren Autor:innen. Beteiligte Einrichtung: "Streinth" Laboratory, University of Strasbourg, INSERM UMR_S 1113, Strasbourg, France. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Stomach Neoplasms, Antineoplastic Agents, Zinc. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Contre le Cancer, German Research Foundation, Structural Genomics Consortium (SGC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Stomach NeoplasmsAntineoplastic AgentsZincChelating AgentsCyclin-Dependent Kinase Inhibitor p21HumansDrug Screening Assays, AntitumorStructure-Activity RelationshipDose-Response Relationship, DrugMolecular StructureCell ProliferationMutationCell SurvivalDrug Evaluation, PreclinicalCell Line, Tumor

Stichwörter der Autor:innen

covalent drugsgastric cancermetal chelationp53targeted therapy

Substanzen

Tumor Suppressor Protein p53Antineoplastic AgentsZincChelating AgentsCyclin-Dependent Kinase Inhibitor p21TP53 protein, human

Autor:innen und Institutionen

  • "Streinth" Laboratory, University of Strasbourg, INSERM UMR_S 1113, Strasbourg, France.
  • "SMART" Laboratory, University of Strasbourg, INSERM UMR_S 1113, Strasbourg, France.
  • Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, Brighton, East Sussex, UK.
  • Department of Chemistry, School of Life Sciences, University of Sussex, Brighton, East Sussex, UK.
  • EastCHEM School of Chemistry, University of Edinburgh, Joseph Black Building, Edinburgh, UK.
  • Department of Inorganic and Analytical Chemistry, University of Debrecen, Debrecen, Hungary.

Förderung

  • Ligue Contre le Cancer
  • German Research Foundation
  • Structural Genomics Consortium (SGC
  • European Partnership Development Fellowship
  • ITI Innovec
  • Itmo Cancer PCSI

Zitieren

APA

Nannini, S., Sieffert, C., McGown, A., Gao, X. Y., Jarvis, A., Kostakis, G. E., Galvacsi, A., Kallay, C., Moraru, R., Baud, M. G., Mandel, S., Balourdas, D. I., Joerger, A. C., Orvain, C., Peschard, S., Nion, A., Mellitzer, G., Lottiaux, S., Spencer, J., …, & Gaiddon, C. (2026). In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity. Journal of Enzyme Inhibition and Medicinal Chemistry, 41(1). https://doi.org/10.1080/14756366.2026.2638836

Vancouver

Nannini S, Sieffert C, McGown A, Gao XY, Jarvis A, Kostakis GE, et al. In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity. Journal of Enzyme Inhibition and Medicinal Chemistry. 2026;41(1). doi:10.1080/14756366.2026.2638836

BibTeX
@article{Nannini2026,
  author = {Nannini, Simon and Sieffert, Céline and McGown, Andrew and Gao, Xin-Yue and Jarvis, Amanda and Kostakis, Georges E and Galvacsi, Antal and Kallay, Csilla and Moraru, Ruxandra and Baud, Matthias G and Mandel, Sebastian and Balourdas, Dimitros-Ilias and Joerger, Andreas C and Orvain, Christophe and Peschard, Simon and Nion, Audrey and Mellitzer, Georg and Lottiaux, Sophie and Spencer, John and Gross, Isabelle and Gaiddon, Christian},
  title = {In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2026},
  volume = {41},
  number = {1},
  doi = {10.1080/14756366.2026.2638836}
}
Kostenlos starten →